| A comprehensive review on tyrosinase inhibitors |
113 |
| Zinc binding groups for histone deacetylase inhibitors |
29 |
| Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? |
28 |
| Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms |
27 |
| Recent developments on triazole nucleus in anticonvulsant compounds: a review |
19 |
| Discovery of novel 3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors |
18 |
| Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, in vitro biological evaluation, and QSAR studies |
17 |
| The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy |
17 |
| Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy |
16 |
| Isothiocyanates: cholinesterase inhibiting, antioxidant, and anti-inflammatory activity |
14 |
| Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation |
14 |
| Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates |
14 |
| Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents |
14 |
| Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors |
14 |
| Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity |
13 |
| Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates |
13 |
| Carbazole scaffolds in cancer therapy: a review from 2012 to 2018 |
13 |
| Novel sulphonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers |
12 |
| Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[3-d]pyrimidine scaffold |
12 |
| Activation of alpha beta gamma- delta zeta- and eta- class of carbonic anhydrases with amines and amino acids: a review |
12 |
| Extraction and derivatisation of active polysaccharides |
11 |
| Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation |
11 |
| Evaluation of a flavonoids library for inhibition of pancreatic alpha-amylase towards a structure-activity relationship |
11 |
| Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies |
11 |
| A novel series of pyrazole-platinum(II) complexes as potential anti-cancer agents that induce cell cycle arrest and apoptosis in breast cancer cells |
11 |
| Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold |
11 |
| Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61 |
11 |
| Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress |
11 |
| In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N-N-3-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide |
10 |
| N-thioalkylcarbazoles derivatives as new anti-proliferative agents: synthesis, characterisation and molecular mechanism evaluation |
10 |
| Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease |
10 |
| Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents |
10 |
| Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails |
10 |
| Advances in the discovery of cathepsin K inhibitors on bone resorption |
10 |
| Profiling donepezil template into multipotent hybrids with antioxidant properties |
10 |
| Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach |
9 |
| Anti-Helicobacter pylori activity of ethoxzolamide |
9 |
| Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents |
9 |
| Mono-and di-thiocarbamate inhibition studies of the delta-carbonic anhydrase TweCA delta from the marine diatom Thalassiosira weissflogii |
9 |
| Identification of new allosteric sites and modulators of AChE through computational and experimental tools |
9 |
| SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs |
8 |
| Evaluation of caffeine as inhibitor against collagenase, elastase and tyrosinase using in silico and in vitro approach |
8 |
| Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid |
8 |
| Tricyclic coumarin sulphonate derivatives with alkaline phosphatase inhibitory effects: in vitro and docking studies |
8 |
| Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma |
8 |
| Identification and characterization of the alpha-CA in the outer membrane vesicles produced by Helicobacter pylori |
8 |
| Synthesis and structure-activity relationships of 2-and/or 4-halogenated 13 beta- and 13 alpha-estrone derivatives as enzyme inhibitors of estrogen biosynthesis |
8 |
| 4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis |
7 |
| Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors |
7 |
| Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-kB activation |
7 |
